Trust Size
$1.1B
Peak Price
$634.56
Current Price
$8.00
Return
-30.1%
Price Journey
What Happened
Ginkgo Bioworks is a synthetic biology platform company that engineers organisms for customers across industries including pharmaceuticals, food, agriculture, and chemicals. The company went public via SPAC merger with Soaring Eagle Acquisition Corp in 2021 at a $15 billion valuation.
Soaring Eagle Acquisition Corp merged with Ginkgo Bioworks in September 2021 at a $15 billion valuation. The stock initially soared but then collapsed as revenue growth disappointed and the company's biosecurity division (acquired during COVID) wound down. Ginkgo has undergone significant restructuring, pivoting toward autonomous labs and AI-driven biology. The stock trades at a fraction of its peak but the company continues to operate.
Timeline
2021-02-22
S-1 Registration Filed
🔀 Reverse Stock Split
Reverse split ratio: . Reverse splits are used to avoid delisting but destroy shareholder value through the illusion of a higher stock price.
SEC Filing Details
CIK Number
1830214
Total SEC Filings
1004
State of Incorporation
DE
Last Filing Date
2026-03-18
Business Location
Los Angeles, CA
Trust/Asset Size
$1.1B
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
📄 SEC Filings
View all EDGAR filings for Ginkgo Bioworks Holdings